ATH
Click for more information
0.00% 0.3¢ alterity therapeutics limited

Progress, page-27

  1. skint
    5,886 Posts.
    lightbulb Created with Sketch. 150
    clock Created with Sketch.
    27/08/17
    14:46
    Post #: 26788320
    Thanks for putting in that work ITM, which made it easier to understand that IMAGINE was not adequately powered to prove or disprove much at all, when addition or removal of one patient can change the result of the trial. In this case it was the trial design which failed the drug.
    Last edited by skint: 27/08/17
    PBT Price at posting: 5.3¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GRX GreenX picks up prospective copper project in Germany
right-arrow Created with Sketch.
DVP Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place
right-arrow Created with Sketch.
NEWS A Super PITch is key in the competition for capital
right-arrow Created with Sketch.
NXG Cost blow-out for Rook I uranium project sees share plummet for NexGen
right-arrow Created with Sketch.
WGX Westgold sets its sights on top five producer status through merger with Karora
right-arrow Created with Sketch.
VMS Venture to sniff out high-grade REE targets at Jupiter project, WA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $1.633K 487.8K

Buyers (Bids)

No. Vol. Price($)
20 32189472 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126368541 15
View Market Depth
Last trade - 16.10pm 08/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.